CGEM PEER ANALYSIS

Cullinan Oncology LLC — metric-by-metric comparison with peers and the industry median

CGEMCullinan Oncology LLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CGEMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CGEM	MSB	TLX	RTALB	CSL	Ind. Median
P/E	—	—	—	4.78●	29.96	18.06
P/B	2.94	—	6.38	0.59●	2.24	3.62
EV/EBITDA	—	—	120.20	72.98	10.35●	15.13
P/S	—	31.30	3.24	6.52	2.66●	10.65

Financial Health
Metric	CGEM	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	10.28●	—	1.43	1.21	2.57	5.90
Debt/Equity	0.7%●	—	112.3%	1.2%	67.4%	10.9%
NetDebt/EBITDA	1.58	—	13.13	0.90●	2.22	1.15

Profitability
Metric	CGEM	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	—	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	-48.2%	-11.3%	-1.8%	15.1%●	7.7%	-47.5%
ROA	-45.0%	-8.6%	-0.7%	13.1%●	3.8%	-35.8%
EBITDA Margin	—	-76.6%	3.0%	9.0%	32.8%●	-105.8%

Growth + Dividend
Metric	CGEM	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	—	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	—	—	—	134.0%●	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	CGEM	ANNX	REPL	KURA	SANA	JANX	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	2.94	6.11	6.39	9.85	9.57	1.07●	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	—	—	—	14.83●	—	46.83	10.65

Financial Health
Metric	CGEM	ANNX	REPL	KURA	SANA	JANX	Ind. Median
Current Ratio	10.28	6.35	4.79	6.15	1.29	17.01●	5.90
Debt/Equity	0.7%●	12.4%	17.0%	22.5%	63.2%	2.3%	10.9%
NetDebt/EBITDA	1.58	1.03	0.77	1.90	0.14●	8.31	1.15

Profitability
Metric	CGEM	ANNX	REPL	KURA	SANA	JANX	Ind. Median
Net Margin	—	—	—	-411.2%●	—	-529.7%	-125.7%
ROE	-48.2%	-87.6%	-107.9%	-124.7%	-147.4%	-11.7%●	-47.5%
ROA	-45.0%	-69.4%	-71.0%	-42.2%	-59.1%	-11.0%●	-35.8%
EBITDA Margin	—	—	—	-408.0%●	—	-520.3%	-105.8%

Growth + Dividend
Metric	CGEM	ANNX	REPL	KURA	SANA	JANX	Ind. Median
Rev. Growth	—	-100.0%	-100.0%	5.4%	-100.0%	2,522.9%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	0.1%	—	—	—	—	0.2%
Payout	—	-0.9%	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CGEM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.